Report Categories
View AllRecent Articles
View All
EQHC Equitable highlights resilient demand for its fixed rate preferred securities in quarterly earnings release
Is Red River RRBI stock undervalued Red River notches 51 EPS beat on steady regional banking performance
EME EMCOR Group beats Q1 2026 estimates by 149 with EPS of 684 signaling robust specialty construction demand
Sachem SCCD Stock What Drives Its Price Steady Decline 20260420
Is Streamex STEX stock gaining momentum Smart Money Exits 20260420
Albemarle Corporation ALB High Probability of Q1 2026 Earnings Beat Amid Lithium Market Upcycle
Is MannKind Corporation MNKD a value trap or a value play Rocket Higher 20260506
SPDR SP Semiconductor ETF XSD A Diversified Alternative to Concentrated LargeCap Semiconductor Exposure
Moodys Corporation MCO Belgian Sovereign Rating Downgrade Triggers European Fixed Income Volatility Fiscal Repricing Risks
Xeris XERS Drops 417 Key Support at 568 20260518
NBT Bancorp NBTB Stock Jumps 076 Approaching 4712 20260514
Las Vegas LVS Climbs 089 Resistance at 5366 in Focus 20260515
Travere Therapeutics TVTX Slips 147 Testing 4015 Support 20260519
Genworth Financial GNW Q1 2026 Earnings Miss Sparks Concern
Brace for the Most Volatile Summer at the Pump in Years Analysts Warn
Teslas AI Pivot Draws Paul Tudor Jones Billionaire Boosts TSLA Stake 9Fold
Anthropic and US Government Face Off in Court Over Defense Department Blacklisting
SFBS Q1 2026 Earnings Modest EPS Beat Amid Stable Banking Operations
EGO Q1 2026 Earnings EPS Surges Past Estimates by 33 Amid Operational Gains
GDEV Q4 2025 Earnings EPS Miss Pressures Stock Despite Lack of Revenue Disclosure
Ovintiv Inc OVV Q1 2026 Earnings EPS Beats Estimates Amid Solid Execution
Lixte Biotechnology Holdings Inc LIXT Q4 2024 Earnings Net Loss of 027 Per Share as Pipeline Progress Continues
Devon Energy Holds Steady Near 47 as Traders Weigh Support and Resistance Levels
BlackRock Taxable Municipal Bond Trust BBN Edges Higher as IncomeSeeking Investors Return
Kemper Corporation KMPR Holds Near Resistance Amid Modest Gains
Ionis Pharmaceuticals IONS Edges Higher as Biotech Sector Holds Steady